Quantitative benefit-harm assessment for setting research priorities: The example of roflumilast for patients with COPD

Milo A. Puhan, Tsung Yu, Cynthia M. Boyd, Gerben ter Riet

研究成果: Article › 同行評審

10 引文 斯高帕斯（Scopus）

指紋

深入研究「Quantitative benefit-harm assessment for setting research priorities: The example of roflumilast for patients with COPD」主題。共同形成了獨特的指紋。

Medicine & Life Sciences